Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway
Shivaksh Ahluwalia(Indian Institute of Technology Delhi), Perumal Vivekanandan(Indian Institute of Technology Delhi), Khadija Dabeer(Indian Institute of Technology Delhi), Vinay Kamuju(ETH Zurich), Belal Ahmad(London Health Sciences Centre), Arpita Ghosh, Dipannita Ghosh(Indian Institute of Technology Delhi), M. Menon(Indian Institute of Technology Delhi), Uzma Salim(Indian Institute of Technology Delhi)
Cited by 12
Related Papers
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
|The Lancet|2019|1.9k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
|Carcinogenesis|2005|267
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial
|BMC Cancer|2019|267
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
|International Journal of Radiation Oncology*Biology*Physics|2022|204